-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

723.O1.6 723. Allogeneic Transplantation: Long-Term Follow-Up and Disease Recurrence: Long-Term Survival and Survivorship From Clinical Trials And Observations

Symposia: Allogeneic Transplantation: Long-term Follow-up and Disease Recurrence Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Clinical Research, health outcomes research, survivorship
Saturday, December 9, 2023: 2:00 PM-3:30 PM
Room 7 (San Diego Convention Center)
Moderators:
Prakash Satwani, MD, MBBS, and Maria Teresa Lupo Stanghellini, IRCCS Ospedale San Raffaele
Disclosures:
No relevant conflicts of interest to declare.
This oral abstract symposium highlights novel and important research focused on longer-term clinical outcomes following allogeneic transplantation, including survival, disease relapse, late effects and quality-of-life. All of the results and findings presented in this session are from clinical trials or large observational research studies.
2:00 PM

Mary Eapen, MBBS, MS1, Joseph Antin, MD2*, Jakub Tolar, MD, PhD3, Sally Arai, MD4, Mitchell Horwitz, MD5, Jainqun Kou, MPH6*, Eric Leifere, PhD7*, John M. McCarty, MD8, Ryotaro Nakamura, MD9, Michael A. Pulsipher, MD10*, Mary M. Horowitz, MD6 and H Joachim Deeg, MD11*

1Department of Medicine, The Medical College of Wisconsin Inc, Milwaukee, WI
2Dana-Farber Cancer Institute, Boston, MA
3University of Minnesota, Minneapolis, MN
4Stanford University Medical Center, Palo Alto, CA
5Duke University Medical Center, Durham, NC
6Center for International Blood and Marrow Transplant Research, Milwaukee, WI
7National Heart Lung and Blood Institute, Bethesda, MD
8Virginia Commonwealth University Medical Center, Richmond, VA
9Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope National Comprehensive Cancer Center, Duarte, CA
10University of Utah School of Medicine, Salt Lake City, UT
11Fred Hutchinson Cancer Center, Seattle, WA

2:15 PM

Rima M. Saliba, PhD1*, Stephanie J. Lee2, Paul A Carpenter, MD3,4, Catherine J. Lee, MD3, Geoffrey R Hill, MD5, Richard E. Champlin, MD1, Katy Rezvani, MD6, Elizabeth J. Shpall, MD1 and Rohtesh S. Mehta, MD7

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Fred Hutchinson Cancer Center, Seattle, WA
3Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
4Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Seattle Children's Hospital, Seattle, WA
5Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA
6Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M D Anderson Cancer Center, Houston, TX
7Clinical Research Division, Fred Hutchinson Cancer Center, Houston, TX

2:30 PM

Arnon Nagler, MD1, Maud Ngoya2*, Jacques-Emmanuel Galimard3*, Myriam Labopin4*, Igor Wolfgang Blau, MD, PhD5*, Nicolaus Kröger, MD6*, Tobias Gedde-Dahl, MD7*, Thomas Schroeder8*, David Burns, MD, PhD9*, Urpu Salmenniemi10*, Alessandro Rambaldi, M.D.11, Goda Choi12*, Regis Peffault De Latour13*, Jan Vydra, MD14*, Henrik Sengeloev15*, Matthias Eder16*, Stephan Mielke, MD17, Edouard Forcade, MD, PhD18*, Sergey Bondarenko, PhD, MD19*, Fabio Ciceri, MD20* and Mohamad Mohty, MD, PhD21,22

1Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel
2European Society for Blood and Marrow Transplantation, Paris, France
3Statistic and Statistic and Epidemiologic Research Center Sorbonne Paris Cit, Paris, FRA
4EBMT Statistical Unit, Sorbonne University, Saint-Antoine Hospital, AP-HP, INSERM UMRs 938, Paris, France
5Medizinische Klinik m. S. Hämatologie, Onkologie und Tumorimmunologie, Berlin, Germany
6University Hospital Eppendorf, Bone Marrow Transplantation Centre, Hamburg, Germany
7Oslo University Hospital, Oslo, NOR
8Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany
9University Hospital Birmingham NHSTrust, Birmingham, United Kingdom
10Dept of Hematology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland
11Department of Hematology, ASST Papa Giovanni XXIII, Bergamo, ITA
12University Medical Center Groningen (UMCG), Groningen, Netherlands
13Hôpital Saint-Louis,, Paris, France
14Institute of Hematology and Blood Transfusion, Prague 10, CZE
15Rigshospitalet, Copenhagen, Denmark
16Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
17Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska Institute & University Hospital, Stockholm, Stockholms Laen, Sweden
18Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, F-33000, Bordeaux, France
19RM Gorbacheva Research Institute, Pavlov University, Saint-Petersburg, RUS
20IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy
21Saint-Antoine Hospital, Sorbonne University, Paris, France
22Hôpital Saint Antoine, Paris, FRA

2:45 PM

Sitong Chen, MPH1*, Alysia Bosworth1*, Liezl Atencio1*, MHD Monzr Al Malki, MD1, Stephen J. Forman, MD, FACP2, Ryotaro Nakamura, MD3, Saro Armenian, DO, MPH1 and F. Lennie Wong, PhD4

1City of Hope National Medical Center, Duarte, CA
2Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA
3Cellular Immunotherapy Center, Department of Hematology and Hematopoietic Cell Transplantation, Beckman Research Institute of City of Hope, Duarte, CA
4City of Hope, Duarte, CA

3:00 PM

Zhihui Li1*, Qinlong Zheng, MD2*, Keyan Yang2*, Teng Xu3*, Lei Wang1*, Xianxuan Wang1*, Xiaopei Wen1*, Yanzhi Song1*, Yongqiang Zhao1* and Tong Wu, MD4

1Department of Bone Marrow Transplantation, Beijing Gaobo Boren Hospital, Beijing, China
2Department of Medical Laboratory, Beijing Gaobo Boren Hospital, Beijing, China
3Department of Data Management, Beijing Gaobo Boren Hospital, Beijing, China
4Department of Bone Marrow Transplantation, Beijing Gobroad Boren Hospital, Beijing, China

3:15 PM

Mazin Mohamed Abdulsalam1,2,3,4*, Bader Alahmari, MD2,5,6*, Ahmed S. Alaskar, MD, FRCPC1,2,3,4*, Ayman Alhejazi1,4,7,8*, Hind Salama, MD2,5,9*, Abdulrahman Al Raizah, MD2,5,9, Abdullah Alsaleh, MD1,2,3*, Ayman Ibrahim, MD5*, Mohammed Bakkar, MD5*, Ayel Yahya, MD5*, Abdul Rauf Ghori, MD5*, Zied Aljubour1*, Rawan Almohammadi1*, Tahani Alanazi1*, Rasha Ahmed1*, Amani Alharbi1*, Inaam Shehabeddine1*, Maybelle Ballili1*, Husam Mazin Alsadi, MD5* and Mohsen Alzahrani, MD2,4,5,9*

1King Abdulaziz Medical City, Ministry of National Guard – Health Affairs, Riyadh, Saudi Arabia
2King Abdullah International Medical Research Center, Riyadh, Saudi Arabia
3King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
4Saudi Scientific Society of Blood and Marrow Transplantation (SSBMT), Riyadh, Saudi Arabia
5Divison of Hematology & HSCT, Departement of Oncology, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia
6King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
7king Abdulah international medical research center KAIMRC, Riyadh, Saudi Arabia
8oncology department, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
9College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia

*signifies non-member of ASH